Ligand to Participate in May Investor Conferences
Ligand Pharmaceuticals announced that its senior management team will participate in a series of investor conferences throughout May 2026. Scheduled events include the H.C. Wainwright Royalty Company Conference, Bank of America Healthcare Conference, and RBC Capital Markets Global Healthcare Conference, featuring both fireside chats and one-on-one meetings. CEO Todd Davis is set to speak at the H.C.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.